Tech Company Financing Transactions
Inivata Funding Round
Inivata, based in Research Triangle Park, received $52.6 million from Cambridge Innovation Capital, IP Group and Johnson & Johnson Development Corporation.
Transaction Overview
Company Name
Announced On
4/1/2019
Transaction Type
Venture Equity
Amount
$52,600,000
Round
Series B
Investors
Proceeds Purpose
The funds will be used to advance the US commercial roll-out of the Company's InVisionFirst-Lung liquid biopsy test, which recently received coverage determination for US Medicare patients with advanced non-small cell lung cancer (NSCLC), paving the way for the test to be used in routine clinical care.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7020 Kit Creek Rd. 140
Research Triangle Park, NC 27560
USA
Research Triangle Park, NC 27560
USA
Phone
Website
Email Address
Not Recorded
Overview
A clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clive Morris
Chief Financial Officer
Timothy Shannon
Chief Information Officer
Charlie Kesinger
Chief Operating Officer
Jamie Platt
Chief Scientific Officer
Nitzan Rosenfeld
VP - Bus. Development
Stacy Chick
Browse more venture capital transactions:
Prev: 4/1/2019: Novo venture capital transaction
Next: 4/1/2019: Toast venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs